Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
5.61
-0.61 (-9.80%)
Nov 15, 2024, 2:13 PM EST - Market open
Voyager Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 163.78 | 250.01 | 40.91 | 37.42 | 171.13 | 104.39 | Upgrade
|
| Revenue Growth (YoY) | 3.40% | 511.16% | 9.33% | -78.14% | 63.93% | 1270.14% | Upgrade
|
| Cost of Revenue | 117.54 | 92.17 | 60.76 | 73.79 | 108.75 | 119.74 | Upgrade
|
| Gross Profit | 46.24 | 157.84 | -19.86 | -36.37 | 62.38 | -15.34 | Upgrade
|
| Selling, General & Admin | 37.17 | 35.82 | 30.98 | 37.25 | 34.99 | 36.34 | Upgrade
|
| Operating Expenses | 37.17 | 35.82 | 30.98 | 37.25 | 34.99 | 36.34 | Upgrade
|
| Operating Income | 9.08 | 122.01 | -50.84 | -73.62 | 27.38 | -51.68 | Upgrade
|
| Interest Expense | - | - | - | -0.39 | - | - | Upgrade
|
| Interest & Investment Income | 17.49 | 11.72 | 1.79 | - | 1.66 | 6.46 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.22 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 26.78 | 133.74 | -49.05 | -74.01 | 29.04 | -45.22 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0 | 0 | 2.65 | 2.81 | 7.7 | 1.63 | Upgrade
|
| Pretax Income | 26.78 | 133.74 | -46.39 | -71.2 | 36.74 | -43.6 | Upgrade
|
| Income Tax Expense | 0.9 | 1.41 | 0.02 | - | - | - | Upgrade
|
| Net Income | 25.88 | 132.33 | -46.41 | -71.2 | 36.74 | -43.6 | Upgrade
|
| Net Income to Common | 25.88 | 132.33 | -46.41 | -71.2 | 36.74 | -43.6 | Upgrade
|
| Shares Outstanding (Basic) | 55 | 43 | 38 | 38 | 37 | 36 | Upgrade
|
| Shares Outstanding (Diluted) | 56 | 45 | 38 | 38 | 37 | 36 | Upgrade
|
| Shares Change (YoY) | 34.11% | 16.20% | 1.83% | 0.86% | 4.04% | 11.95% | Upgrade
|
| EPS (Basic) | 0.47 | 3.08 | -1.21 | -1.89 | 0.99 | -1.21 | Upgrade
|
| EPS (Diluted) | 0.47 | 2.97 | -1.21 | -1.89 | 0.98 | -1.21 | Upgrade
|
| Free Cash Flow | -28.66 | 74.66 | -15 | -55.13 | -108.81 | 40.95 | Upgrade
|
| Free Cash Flow Per Share | -0.51 | 1.68 | -0.39 | -1.46 | -2.91 | 1.14 | Upgrade
|
| Gross Margin | 28.23% | 63.13% | -48.54% | -97.21% | 36.45% | -14.70% | Upgrade
|
| Operating Margin | 5.54% | 48.80% | -124.27% | -196.76% | 16.00% | -49.51% | Upgrade
|
| Profit Margin | 15.80% | 52.93% | -113.45% | -190.29% | 21.47% | -41.76% | Upgrade
|
| Free Cash Flow Margin | -17.50% | 29.86% | -36.67% | -147.36% | -63.59% | 39.23% | Upgrade
|
| EBITDA | 14.13 | 126.46 | -44.65 | -68.45 | 31.2 | -48.91 | Upgrade
|
| EBITDA Margin | 8.63% | 50.58% | -109.14% | -182.96% | 18.23% | -46.86% | Upgrade
|
| D&A For EBITDA | 5.06 | 4.44 | 6.19 | 5.17 | 3.82 | 2.77 | Upgrade
|
| EBIT | 9.08 | 122.01 | -50.84 | -73.62 | 27.38 | -51.68 | Upgrade
|
| EBIT Margin | 5.54% | 48.80% | -124.27% | -196.76% | 16.00% | -49.51% | Upgrade
|
| Effective Tax Rate | 3.37% | 1.05% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.